MARKET

RDPTF

RDPTF

Radiopharm Theranostics Ltd
OTCPK
0.020
NaN%
Opening 09:30 12/19 EST
OPEN
--
PREV CLOSE
0.020
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.020
52 WEEK LOW
0.020
MARKET CAP
70.88M
P/E (TTM)
-1.7241
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDPTF last week (0908-0912)?
Weekly Report · 09/15 10:59
Weekly Report: what happened at RDPTF last week (0901-0905)?
Weekly Report · 09/08 11:01
Weekly Report: what happened at RDPTF last week (0825-0829)?
Weekly Report · 09/01 10:57
Weekly Report: what happened at RDPTF last week (0818-0822)?
Weekly Report · 08/25 11:06
Weekly Report: what happened at RDPTF last week (0811-0815)?
Weekly Report · 08/18 10:59
Weekly Report: what happened at RDPTF last week (0804-0808)?
Weekly Report · 08/11 11:05
Weekly Report: what happened at RDPTF last week (0728-0801)?
Weekly Report · 08/04 11:08
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
Barchart · 07/29 06:30
More
About RDPTF
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including OTCPK: RDPTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDPTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDPTF stock methods without spending real money on the virtual paper trading platform.